ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SUPN Supernus Pharmaceuticals Inc

30.25
0.15 (0.50%)
Last Updated: 12:34:52
Delayed by 15 minutes

Period:

Draw Mode:

Volume 148,868
Bid Price 30.26
Ask Price 30.30
News (1)
Day High 30.69

Low
21.99

52 Week Range

High
38.09

Day Low 29.99
Share Name Share Symbol Market Stock Type
Supernus Pharmaceuticals Inc SUPN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.15 0.50% 30.25 12:34:52
Open Price Low Price High Price Close Price Previous Close
30.15 29.99 30.69 30.10
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,028 148,868 US$ 30.24 US$ 4,502,466 - 21.99 - 38.09
Last Trade Type Quantity Price Currency
12:35:23 3 US$ 30.2939 USD

Supernus Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.66B 54.73M - 609.04M 1.32M 0.02 1,262.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Supernus Pharmaceuticals News

Date Time Source News Article
5/01/202407:00GlobeNewswire Inc.Busy Philipps Shines Spotlight on ADHD in Women and Shares..
4/24/202415:05GlobeNewswire Inc.Supernus Pharmaceuticals to Announce First Quarter 2024..
4/08/202407:00GlobeNewswire Inc.Supernus Provides Regulatory Update for SPN-830
3/06/202415:30GlobeNewswire Inc.Supernus to Participate in Two Upcoming Investor Conferences
2/29/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:00Edgar (US Regulatory)Form 8-K - Current report
2/28/202415:30GlobeNewswire Inc.Supernus to Participate in the TD Cowen 44th Annual..
2/27/202416:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SUPN Message Board. Create One! See More Posts on SUPN Message Board See More Message Board Posts

Historical SUPN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week29.9631.2729.1730.05307,5740.290.97%
1 Month32.8534.4928.6330.70350,384-2.60-7.91%
3 Months28.4035.4426.273331.38399,1841.856.51%
6 Months23.8135.4423.04529.30380,1656.4427.05%
1 Year36.7738.0921.9930.10418,915-6.52-17.73%
3 Years30.5042.0921.9931.27415,844-0.25-0.82%
5 Years36.6542.0913.1228.19475,683-6.40-17.46%

Supernus Pharmaceuticals Description

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others.

Your Recent History

Delayed Upgrade Clock